Navigation Links
BioMed Realty Trust Announces Tax Treatment of 2010 Distributions
Date:1/19/2011

SAN DIEGO, Jan. 19, 2011 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced the tax treatment of its 2010 distributions as follows:Security Description: Common StockCUSIP: 09063H107Ticker Symbol: BMRRecord DatePayable DateTotal Distribution Per ShareAllocable to 2010Taxable Ordinary DividendReturn of CapitalLong-Term Capital GainUnrecaptured Section 1250 Gain12/31/2009

1/15/2010

$0.140000

$0.140000

$0.090527

$0.049473

$0.000000

$0.0000003/31/2010

4/15/2010

$0.140000

$0.140000

$0.090527

$0.049473

$0.000000

$0.0000006/30/2010

7/15/2010

$0.150000

$0.150000

$0.096994

$0.053006

$0.000000

$0.0000009/30/2010

10/15/2010

$0.170000

$0.170000

$0.109926

$0.060074

$0.000000

$0.000000Totals

$0.600000

$0.600000

$0.387974

$0.212026

$0.000000

$0.000000Security Description: 7.375% Series A Cumulative Redeemable Preferred StockCUSIP: 09063H206Ticker Symbol: BMR PR ARecord DatePayable DateTotal Distribution Per ShareAllocable to 2010Taxable Ordinary DividendReturn of CapitalLong-Term Capital GainUnrecaptured Section 1250 Gain12/31/2009

1/15/2010

$0.460940

$0.460940

$0.460940

$0.000000

$0.000000

$0.0000003/31/2010

4/15/2010

$0.460940

$0.460940

$0.460940

$0.000000

$0.000000

$0.0000006/30/2010

7/15/2010

$0.460940

$0.460940

$0.460940

$0.000000

$0.000000

$0.0000009/30/2010

10/15/2010

$0.460940

$0.460940

$0.460940

$0.000000

$0.000000

$0.000000Totals

$1.843760

$1.843760

$1.843760

$0.000000

$0.000000

$0.000000The distributions payable on January 17, 2011 to shareholders of record on December 31, 2010, as previously announced on December 15, 2010, are considered 2011 distributions for federal income tax purposes.

The company did not incur any foreign taxes during 2010.  Stockholders are encouraged to consult with their personal tax advisors as to their specific tax treatment of BioMed Realty Trust distributions.

About BioMed Realty TrustBioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on Providing Real Estate to the Life Science Industry®. The company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed owns or has interests in 85 properties, representing 147 buildings with approximately 12.2 million rentable square feet. The company's properties are located predominantly in the major U.S. life science markets of Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/New Jersey, which have well-established reputations as centers for scientific research.  Additional information is available at www.biomedrealty.com.


'/>"/>

SOURCE BioMed Realty Trust, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dr. Paul Janssen Award for Biomedical Research Issues Call for Nominations
2. BioMedixs TRAKnet Practice Management Software Receives ONC-ATCB 2011/2012 Certification
3. BioMedical Enterprises, Inc. (BME) Introduces the HammerLock™ Shape Memory Device for Hammertoes.
4. Synapse Biomedical Receives FDA Humanitarian Use Device Designation for Amyotrophic Lateral Sclerosis (ALS)
5. DSM Biomedical to be Key Contributor at the Surfaces in Biomaterials Foundations 2010 BioInterface Symposium and Workshop
6. BioMed Realty Trust Announces Exercise of Over-Allotment Option for Common Stock
7. DuPont and DSM Announce Joint Venture in Surgical Biomedical Materials
8. ETC Biomedical Systems Offers New FDA Approved Hyperbaric Oxygen Therapy (HBOT) Medical Device
9. BINDER BIOMEDICAL, INC. Announces Official Launch of the NEWTON™ Intervertebral Body Fusion Spinal Spacer System
10. Crux Biomedical Named One of Top 50 Companies to Watch
11. Crux Biomedical Enrolls First Patient in Its Retrieve 2 U.S. Pivotal Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... , April 28, 2016 ... H1 2016" is a report that provides an ... strengthen R&D pipelines by identifying new targets and ... Company Profiles discussed in this H1 2016 ... Riunite Srl, AbbVie Inc., Abiogen Pharma S.p.A., Ablynx ...
(Date:4/27/2016)... le 27 Avril 2016 ... progressé de +5% sur le trimestre, soutenu par ... consommables  Croissance de +16% des ventes ... Mauna Kea Technologies (Euronext : MKEA, FR0010609263 ; OTCQX : ... laser, annonce aujourd,hui son chiffre d,affaires pour le ...
(Date:4/27/2016)... 27, 2016 Transparency Market Research ... Market - Global Industry Analysis, Size, Share, Growth, Trends, ... the global skincare devices market was valued at US$ ... at a CAGR of 10.1% from 2015 to 2023 ... Browse the full Skincare Devices Market (Treatment Device - LED ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the ... of funding led by Eastside Partners, with participation from existing investor Martin Ventures. ... base and accelerate its technology and product roadmap. , “Jvion is ...
(Date:4/29/2016)... ... 2016 , ... CURE Media Group , the nation’s ... today announced that Lynne Malestic, RN, of Eisenhower Lucy Curci Cancer Center in ... Oncology Nursing , which honors nurses who have dedicated their careers to helping ...
(Date:4/29/2016)... ... April 29, 2016 , ... Natren, Inc. ... line of probiotics, Petbiotics ™, as they fondly call them. As animal ... groups networking for their non-profit organizations. Animal rescues across the nation face huge ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... ... raising awareness for Duchenne muscular dystrophy, and funding for Duchenne research, participated in ... efficacy of the Sarepta Therapeutic’s novel Duchenne drug eteplirsen. The meeting at the ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... 2014. Each year, reproductive endocrinologists are required to report in vitro fertilization ... of professionals dedicated to the practice of assisted reproductive technologies in the United ...
Breaking Medicine News(10 mins):